Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zimlichman

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Journal of Human Hypertension|September 19, 2014
Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertensionJ Dingemanse, P Otasevic, K Shakeri-Nejad, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 14, 2005
Glucagon does not affect catecholamine release in primary cultures of bovine adrenal chromaffin cellsY Sharabi, R Zimlichman, S Alesci, et al.
American Journal of Hypertension|September 1, 1995
Insulin induces medial hypertrophy of myocardial arterioles in ratsR Zimlichman, L Zeidel, D Gefel, et al.
Circulation|March 1, 1996
Expression of opioid receptors during heart ontogeny in normotensive and hypertensive ratsR Zimlichman, D Gefel, H Eliahou, et al.
Nature|January 9, 1986
Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous systemR Udelsman, J P Harwood, M A Millan, et al.
Journal of the Autonomic Nervous System|April 1, 1986
Indices of sympathetic vascular innervation in sympathectomized patientsD S Goldstein, R F Bonner, R Zimlichman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1994
Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cellsJ Barg, M M Belcheva, R Zimlichman, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES StudyK Reinhart, T Menges, B Gardlund, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Journal of Human Hypertension|September 19, 2014
Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertensionJ Dingemanse, P Otasevic, K Shakeri-Nejad, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 14, 2005
Glucagon does not affect catecholamine release in primary cultures of bovine adrenal chromaffin cellsY Sharabi, R Zimlichman, S Alesci, et al.
American Journal of Hypertension|September 1, 1995
Insulin induces medial hypertrophy of myocardial arterioles in ratsR Zimlichman, L Zeidel, D Gefel, et al.
Circulation|March 1, 1996
Expression of opioid receptors during heart ontogeny in normotensive and hypertensive ratsR Zimlichman, D Gefel, H Eliahou, et al.
Nature|January 9, 1986
Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous systemR Udelsman, J P Harwood, M A Millan, et al.
Journal of the Autonomic Nervous System|April 1, 1986
Indices of sympathetic vascular innervation in sympathectomized patientsD S Goldstein, R F Bonner, R Zimlichman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 1994
Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cellsJ Barg, M M Belcheva, R Zimlichman, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES StudyK Reinhart, T Menges, B Gardlund, et al.
Pageof 11